换一批
换一批
作者：
Emily,Stephenson [1]
;
Gary,Reynolds [1]
;
Rachel A,Botting [1]
;
Fernando J,Calero-Nieto [2]
;
Michael D,Morgan [3]
;
Zewen Kelvin,Tuong [4]
;
Karsten,Bach [3]
;
Waradon,Sungnak [5]
;
Kaylee B,Worlock [6]
;
Masahiro,Yoshida [6]
;
Natsuhiko,Kumasaka [5]
;
Katarzyna,Kania [7]
;
Justin,Engelbert [1]
;
Bayanne,Olabi [1]
;
Jarmila Stremenova,Spegarova [8]
;
Nicola K,Wilson [2]
;
Nicole,Mende [2]
;
Laura,Jardine [1]
;
Louis C S,Gardner [1]
;
Issac,Goh [1]
;
Dave,Horsfall [1]
;
Jim,McGrath [1]
;
Simone,Webb [1]
;
Michael W,Mather [1]
;
Rik G H,Lindeboom [5]
;
Emma,Dann [5]
;
Ni,Huang [5]
;
Krzysztof,Polanski [5]
;
Elena,Prigmore [5]
;
Florian,Gothe [9]
;
Jonathan,Scott [8]
;
Rebecca P,Payne [8]
;
Kenneth F,Baker [10]
;
Aidan T,Hanrath [11]
;
Ina C D,Schim van der Loeff [8]
;
Andrew S,Barr [12]
;
Amada,Sanchez-Gonzalez [12]
;
Laura,Bergamaschi [13]
;
Federica,Mescia [13]
;
Josephine L,Barnes [6]
;
Eliz,Kilich [14]
;
Angus,de Wilton [14]
;
Anita,Saigal [15]
;
Aarash,Saleh [15]
;
Sam M,Janes [16]
;
Claire M,Smith [17]
;
Nusayhah,Gopee [18]
;
Caroline,Wilson [19]
;
Paul,Coupland [7]
;
Jonathan M,Coxhead [1]
;
Vladimir Yu,Kiselev [5]
;
Stijn,van Dongen [5]
;
Jaume,Bacardit [20]
;
Hamish W,King [21]
;
Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID-19 BioResource Collaboration [22]
;
Anthony J,Rostron [8]
;
A John,Simpson [8]
;
Sophie,Hambleton [2]
;
Elisa,Laurenti [13]
;
Paul A,Lyons [5]
;
Kerstin B,Meyer [16]
;
Marko Z,Nikolić [11]
;
Christopher J A,Duncan [13]
;
Kenneth G C,Smith [23]
;
Sarah A,Teichmann [24]
;
Menna R,Clatworthy [25]
;
John C,Marioni [26]
;
Berthold,Göttgens [27]
;
Muzlifah,Haniffa
作者单位：
Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.
[1]
Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.
[2]
European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK.;Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
[3]
Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK.;Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
[4]
Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.
[5]
UCL Respiratory, Division of Medicine, University College London, London, UK.
[6]
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
[7]
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.
[8]
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.;Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany.
[9]
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.;NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
[10]
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.;Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation, Newcastle upon Tyne, UK.
[11]
Department of Infection and Tropical Medicine, Newcastle upon Tyne Hospitals NHS Foundation, Newcastle upon Tyne, UK.
[12]
Cambridge Institute of Therapeutic Immunology and Infectious Disease, Jeffrey Cheah Biomedical Centre, Cambridge Biomedical Campus, Cambridge, UK.;Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
[13]
University College London Hospitals NHS Foundation Trust, London, UK.
[14]
Royal Free Hospital NHS Foundation Trust, London, UK.
[15]
UCL Respiratory, Division of Medicine, University College London, London, UK.;University College London Hospitals NHS Foundation Trust, London, UK.
[16]
UCL Great Ormond Street Institute of Child Health, London, UK.
[17]
Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.;Department of Dermatology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
[18]
Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK.;The Innovation Lab Integrated COVID Hub North East, Newcastle Upon Tyne, UK.
[19]
School of Computing, Newcastle University, Newcastle Upon Tyne, UK.
[20]
Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK.;Centre for Immunobiology, Blizard Institute, Queen Mary University of London, London, UK.
[21]
Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.;Integrated Critical Care Unit, Sunderland Royal Hospital, South Tyneside and Sunderland NHS Foundation Trust, Sunderland, UK.
[22]
Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. st9@sanger.ac.uk.;Theory of Condensed Matter Group, Cavendish Laboratory/Department of Physics, University of Cambridge, Cambridge, UK. st9@sanger.ac.uk.
[23]
Molecular Immunity Unit, Department of Medicine, University of Cambridge, Cambridge, UK. mrc38@cam.ac.uk.;Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. mrc38@cam.ac.uk.;Department of Medicine, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. mrc38@cam.ac.uk.;Cambridge Institute for Therapeutic Immunology and Infectious Disease, Cambridge Biomedical Campus, Cambridge, UK. mrc38@cam.ac.uk.;NIHR Cambridge Biomedical Research Centre, Cambridge, UK. mrc38@cam.ac.uk.
[24]
European Molecular Biology Laboratory, European Bioinformatics Institute (EMBL-EBI), Wellcome Genome Campus, Cambridge, UK. marioni@ebi.ac.uk.;Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. marioni@ebi.ac.uk.;Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. marioni@ebi.ac.uk.
[25]
Wellcome - MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK. bg200@cam.ac.uk.
[26]
Biosciences Institute, Newcastle University, Newcastle upon Tyne, UK. m.a.haniffa@ncl.ac.uk.;Wellcome Sanger Institute, Wellcome Genome Campus, Cambridge, UK. m.a.haniffa@ncl.ac.uk.;NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. m.a.haniffa@ncl.ac.uk.;Department of Dermatology, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK. m.a.haniffa@ncl.ac.uk.
[27]
主题词
横断面研究(Cross-Sectional Studies);人类(Humans);单核细胞(Monocytes);蛋白质组(Proteome);受体, 抗原, B细胞(Receptors, Antigen, B-Cell);受体, 抗原, T细胞(Receptors, Antigen, T-Cell);单细胞分析(Single-Cell Analysis);T淋巴细胞(T-Lymphocytes)
DOI
10.1038/s41591-021-01329-2
PMID
33879890
发布时间
2024-08-10
- 浏览0
Nature medicine
Nature medicine
904-916页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
